https://www.barchart.com/stocks/quotes/AIMT/comparison?symbols=AZN%2CAMGN%2CGILD%2CBMY%2CGSK
AIMT Comparison for Aimmune Therap Stock - Barchart.com
Compare Aimmune Therap (AIMT) to other companies with price, technicals, performance, and fundamentals comparison.
aimtcomparisontherapstockbarchart
https://www.fool.com/investing/2019/09/11/did-the-fda-just-signal-smooth-sailing-ahead-for-a.aspx
Did the FDA Just Signal Smooth Sailing Ahead For Aimmune Therapeutics? | The Motley Fool
Sep 12, 2019 - Here's what a benign briefing document means, and what it doesn't.
https://www.biopharmadive.com/news/aimmune-fda-approval-palforzia-peanut-allergy/571524/
FDA approves Aimmune drug as first treatment for peanut allergy | BioPharma Dive
Aimmune's next challenge will be securing insurance coverage as people allergic to peanuts still have to avoid exposure to the food.
fda approves
https://www.fiercebiotech.com/r-d/aimmune-s-peanut-allergy-drug-clears-phase-ii-on-way-to-a-pivotal-test
Aimmune's peanut allergy drug clears Phase II on the way to a pivotal test | Fierce Biotech
Mar 7, 2016 - Brisbane, CA, biotech Aimmune Therapeutics said its in-development treatment for peanut allergies performed well in an open-label study, burnishing the...